Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth)

Navigation and Search

Research

“This is how we can help” – Couple shares their story as COVID-19 clinical trial participants

The couple, who enrolled in separate COVID-19 antibody clinical trials at UTHealth, at their day 29 appointments with Netanya S. Utay, MD. (Photo by: UTHealth)

November 24, 2020

“I don’t feel so great,” my husband, Brandon, said to me one Saturday afternoon – the last thing I wanted to hear after spending the last seven months tuned into COVID-19 media coverage. Knowing a few of his co-workers had recently tested positive for the virus, we didn’t wait to secure an appointment for a rapid test. When he called me an hour later to tell me he has tested positive, my heart sank.


Patient with aortic aneurysm benefits from innovative, minimally invasive procedure

Gustavo Oderich, MD, FACS, checks Rodolfo Sandoval’s heartbeat at his six-week post operation checkup. Oderich repaired Sandoval’s complex aortic aneurysm with a minimally invasive procedure. (Photo by: Caliann Ferguson/UTHealth)

November 19, 2020

When Rodolfo Sandoval was told he would need to undergo open surgery to repair his thoracic and abdominal aortic aneurysm, he hesitated. At 73 years old, he was worried about the recovery process for a major, invasive procedure. Then COVID-19 arrived and he made the decision that he would only consider the surgery if it became a life or death situation.


Researchers seeking volunteers for COVID-19 vaccine study

Carmel B. Dyer, MD, speaks to two trial participants at the UTHealth Clinical Research Unit at Memorial Hermann-Texas Medical Center. (Photo by: Roger Castro/UTHealth)

November 2, 2020

A Phase III clinical trial to assess if a potential vaccine is effective at preventing symptomatic COVID-19 is now open for enrollment by The University of Texas Health Science Center at Houston (UTHealth) in collaboration with Memorial Hermann-Texas Medical Center.




U.S.-born Mexican Americans at greater risk for cardiovascular disease than first-generation immigrants

New research has revealed that early atherosclerosis is associated with excess amounts of abdominal fat in U.S.-born Mexican Americans, but not first-generation immigrants. (Photo by: Getty Images)

October 20, 2020

Early atherosclerosis (measured by increased thickness of the carotid arteries) is associated with excess amounts of abdominal fat in U.S.-born Mexican Americans but not first-generation immigrants, according to research by The University of Texas Health Science Center at Houston (UTHealth). The findings were published recently in the Journal of the American Heart Association.


Researchers awarded over $11 million to study multi-drug resistant infection factors

The study will utilize state-of-the-art analysis of the genomes of multidrug-resistant pathogens and their potential products. (Photo by Getty Images)

October 9, 2020

A study aimed at better understanding why some critically ill patients develop multidrug-resistant infections is underway by researchers at The University of Texas Health Science Center at Houston (UTHealth). The multi-institution study will enroll patients at Memorial Hermann Hospital-Texas Medical Center and The University of Texas MD Anderson Cancer Center.


Team assessing if dual-antibody injection prevents COVID-19 illness

A woman receives a vaccine in her arm. (Photo by: Getty Images)

September 24, 2020

A combination antibody treatment for preventing COVID-19 illness in individuals who have had sustained exposure to someone with the virus is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital.


UTHealth joins NIH trial to test antibodies and other experimental outpatient treatments for mild COVID-19 pneumonia

The first treatment being tested is LY-CoV555, an investigational monoclonal (laboratory-manufactured) antibody developed from the blood sample of a recovered COVID-19 patient. (Photo by: Getty Images)

September 15, 2020

A study on the effectiveness of multiple treatments, including laboratory-made antibodies, at preventing mild COVID-19 from advancing to severe illness in the outpatient setting is underway by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital.


Police officers face multifaceted, compounding stressors that can lead to adverse events during high-stress calls

Three police vehicles in the foreground with crime scene tape. (Photo by Getty Images)

August 18, 2020

Repeated exposure to high-stress calls for service and ongoing exposure to stress without relief were two of the contributing factors that could lead law enforcement officers to become susceptible to adverse events while performing their duties, according to a new study published in BMC Public Health by researchers at The University of Texas Health Science Center at Houston (UTHealth).



Page 1 of 23

More headlines »

Search UTHealth News

Use the form below to perform a new search.

Give to UTHealth